Impaired Fasting Glucose Is the Major Determinant of the 20‐Year Mortality Risk Associated With Metabolic Syndrome in Nondiabetic Patients With Stable Coronary Artery Disease

Impaired Fasting Glucose Is the Major Determinant of the 20‐Year Mortality Risk Associated With Metabolic Syndrome in Nondiabetic Patients With Stable Coronary Artery Disease

BackgroundWe wanted to explore the association of metabolic syndrome (MetS) versus its individual components with 20‐year all‐cause mortality among patients with stable coronary artery disease. Methods and ResultsThe cohort comprised 12 403 nondiabetic patients with stable coronary artery disease wh...

Full description

Bibliographic Details
Main Authors: Arwa Younis, Ronen Goldkorn, Ilan Goldenberg, Diklah Geva, Boaz Tzur, Anna Mazu, Anan Younis, Zvi Fisman, Alexander Tannenbaum, Robert Klempfner
Format: Article
Language:English
Published: Wiley 2017-11-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
impaired glucose tolerance
metabolic syndrome
mortality
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.117.006609

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.117.006609

Similar Items